» Emisphere Announces Recruitment Of Novartis Phase III Study For Oral Osteoporosis Treatment
Emisphere Technologies, Inc. (Nasdaq: EMIS) announced that Novartis Pharma AG has finished recruitment for a multi-center Phase III study exploring the safety and efficacy of Salmon Calcitonin and…